I throw this out for discussion. When the N Assay

I throw this out for discussion. When the N Assay gets published and if there is more products for the interested party, would a reverse split be a possibility? Might this not move us to a bigger board? Of course this all depends on a successful N Assay. This has worked for LXRX.